Statistics

Total Visits

Views
A randomized, phase 1/2 trial of the safety, tolerability, and immunogenicity of bivalent rLP2086 meningococcal B vaccine in healthy infants57

Select a period of time:

Number of views in the range

Views
A randomized, phase 1/2 trial of the safety, tolerability, and immunogenicity of bivalent rLP2086 meningococcal B vaccine in healthy infants28

Views

Views
October 20242
November 20242
December 20241
January 20252
February 20257
March 202514
April 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore14
United States13
United Kingdom1
 

Top cities views

Views
Buffalo1
Pasadena1
Scottsdale1